Aligos Therapeutics (5WK0.MU) Q1 2026 Earnings

5MarConfirmed
Q1 2026
-2.14
-1.98
-1.81
-1.65

Details

Expected EPS
-2.1418369137
Actual EPS
-1.6450829999999999
Surprise EPS
0.5
Surprise Percent
+23.19%

Description

Aligos Therapeutics (5WK0.MU) has reported earnings of -1.6450829999999999 per share for Q1 2026.

0 Comments

Share your thoughts